Finland· FI-REL-REL4919
Lanvis
A tioguanine product, registered in Finland by The Wellcome Foundation Limited. The same ATC class is registered in 13 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Tioguanine is registered in 13 of 19 countries.
Countries holding a registration under ATC L01BB03 (tioguanine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Tioguanine · ATC L01BB03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Germany
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Manufacturer
- The Wellcome Foundation Limited
- Country
- Finland (FI)
- ATC code
- L01BB03
- ATC class
- Tioguanine
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
434 interactions on record for tioguanine.
Graded by severity as the source publishes them — 33 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tioguanine · interactions on record
434 records
- 33 severe
- 377 moderate
- 13 minor
- 11 info
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CladribineL01BB04severe
- ClotrimazoleA01AB18moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L01BB03
Tioguanine, as other registers publish it.
- SwitzerlandLanvis
- NorwayLanvisGlaxoSmithKline
- PolandLanvisAspen Pharma Trading Ltd.
- CzechiaLANVISAspen Pharma Trading Limited, Dublin
- CanadaLANVISASPEN PHARMACARE CANADA INC.
- BelgiumLanvis 40 mgAspen Pharma Trading
- NetherlandsLanvis 40 mg tablettenAspen Pharma Trading Limited
- United KingdomLanvis 40mg tabletsAspen Pharma Trading Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/224a0bae-d941-4e13-a4f3-45473a4781bc GET /v1/drugs/224a0bae-d941-4e13-a4f3-45473a4781bc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "tabletti",
"route": null,
"ddd_unit": null,
"strength": "40 mg",
"atc_label": "tioguaniini",
"ma_number": "10341",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL4919",
"authorised_at": "1990-11-28"
}See everything about tioguanine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.